FDA Delay Shuts Down Biotech; Demand Rises for Oral Weight Loss Pills
The U.S. Pharmaceutical landscape is currently witnessing a dichotomy of volatility and growth. While regulatory delays at the FDA have forced the closure of Kezar Life Sciences, the obesity market ... Read More